Phase 1 Study of PF-07257876 in Participants With Selected Advanced Tumors
A Phase 1 Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PF-07257876 in Patients With Advanced or Metastatic Tumors
Category & Conditions: Cancer
Medicine: PF-07257876
ClinicalTrials.gov Identifier (NCT): NCT04881045
Protocol ID: C4401001
Open Plain Language Summary Result:
Click here